These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22452262)

  • 1. Pharmacokinetics, bioavailability and metabolism of rhaponticin in rat plasma by UHPLC-Q-TOF/MS and UHPLC-DAD-MSn.
    Zhao YY; Su Q; Cheng XL; Tan XJ; Bai X; Lin RC
    Bioanalysis; 2012 Mar; 4(6):713-23. PubMed ID: 22452262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple and rapid spectrofluorimetric method for determining the pharmacokinetics and metabolism of rhaponticin in rat plasma, feces and urine using a cerium probe.
    Sun Y; Zhao Y; Yang X
    Luminescence; 2013; 28(4):523-9. PubMed ID: 23364836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside in rat using ultra-performance LC-quadrupole TOF-MS.
    Zhao YY; Zhang L; Feng YL; Chen DQ; Xi ZH; Du X; Bai X; Lin RC
    J Sep Sci; 2013 Mar; 36(5):863-71. PubMed ID: 23371758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparative enzymatic synthesis and HPLC analysis of rhapontigenin: applications to metabolism, pharmacokinetics and anti-cancer studies.
    Roupe KA; Helms GL; Halls SC; Yáñez JA; Davies NM
    J Pharm Pharm Sci; 2005 Aug; 8(3):374-86. PubMed ID: 16401387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma pharmacokinetics and tissue distribution study of cajaninstilbene acid in rats by liquid chromatography with tandem mass spectrometry.
    Hua X; Fu YJ; Zu YG; Wu N; Kong Y; Li J; Peng X; Efferth T
    J Pharm Biomed Anal; 2010 Jun; 52(2):273-9. PubMed ID: 20116956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS/TOF and UHPLC-MS/MS study of in vivo fate of rifamycin isonicotinyl hydrazone formed on oral co-administration of rifampicin and isoniazid.
    Prasad B; Singh S
    J Pharm Biomed Anal; 2010 Jul; 52(3):377-83. PubMed ID: 19692195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of Rhaponticin and Activities of its Metabolite, Rhapontigenin: A Review.
    Chen D; Liu JR; Cheng Y; Cheng H; He P; Sun Y
    Curr Med Chem; 2020; 27(19):3168-3186. PubMed ID: 30666906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of selected stilbenes: rhapontigenin, piceatannol and pinosylvin in rats.
    Roupe KA; Yáñez JA; Teng XW; Davies NM
    J Pharm Pharmacol; 2006 Nov; 58(11):1443-50. PubMed ID: 17132206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences pharmacokinetics, bioavailability, hepatic metabolism and metabolism studies of Pinnatifolone A, a sesquiterpenoid compound, in rats by LC-MS/MS and UHPLC-Q-TOF-MS/MS.
    Peng W; Li Z; Cai D; Yi X; Yue Jeff Zhang J; Zhong G; Ouyang H; Feng Y; Yang S
    Phytomedicine; 2023 Jan; 109():154544. PubMed ID: 36610155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic and antiallergic activities of rhaponticin from Rhei Rhizoma are activated by human intestinal bacteria.
    Park EK; Choo MK; Yoon HK; Kim DH
    Arch Pharm Res; 2002 Aug; 25(4):528-33. PubMed ID: 12214867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, bioavailability, excretion, and metabolic analysis of Schisanlactone E, a bioactive ingredient from Kadsura heteroclita (Roxb) Craib, in rats by UHPLC-MS/MS and UHPLC-Q-Orbitrap HRMS.
    Liu R; Liu Q; Li B; Liu L; Cheng D; Cai X; Liu W; Wang W
    J Pharm Biomed Anal; 2020 Jan; 177():112875. PubMed ID: 31546138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced pharmacokinetics and anti-tumor efficacy of PEGylated liposomal rhaponticin and plasma protein binding ability of rhaponticin.
    Sun Y; Zhao Y
    J Nanosci Nanotechnol; 2012 Oct; 12(10):7677-84. PubMed ID: 23421127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of GC-TOF MS and UHPLC-(Q)TOF MS to investigate the presence of nontarget pollutants and their metabolites in a case of honeybee poisoning.
    Portolés T; Ibáñez M; Sancho JV; López FJ; Hernández F
    J Agric Food Chem; 2009 May; 57(10):4079-90. PubMed ID: 19382786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma.
    Xu W; Sun J; Zhang TT; Ma B; Cui SM; Chen DW; He ZG
    Acta Pharmacol Sin; 2006 Dec; 27(12):1642-6. PubMed ID: 17112421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of A HPLC-MS assay versus an UHPLC-MS/MS for anti-tumoral alkyl lysophospholipid edelfosine determination in both biological samples and in lipid nanoparticulate systems.
    Estella-Hermoso de Mendoza A; Campanero MA; Mollinedo F; Blanco-Príeto MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(31):4035-41. PubMed ID: 19896423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetate.
    Jia L; Coward LC; Kerstner-Wood CD; Cork RL; Gorman GS; Noker PE; Kitada S; Pellecchia M; Reed JC
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):63-73. PubMed ID: 17356822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral absorption, distribution, metabolism, and excretion of icaritin in rats by Q-TOF and UHPLC-MS/MS.
    Zhang SQ; Zhang SZ
    Drug Test Anal; 2017 Oct; 9(10):1604-1610. PubMed ID: 28303675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of oxyresveratrol analog trans-2,4,3',5'-tetramethoxystilbene in rat plasma by a rapid HPLC method: application in a pre-clinical pharmacokinetic study.
    Lin HS; Choo QY; Ho PC
    Biomed Chromatogr; 2010 Dec; 24(12):1373-8. PubMed ID: 21077256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and Metabolism Study of Deep-Sea-Derived Butyrolactone I in Rats by UHPLC-MS/MS and UHPLC-Q-TOF-MS.
    Wu L; Xie CL; Yang XW; Chen G
    Mar Drugs; 2021 Dec; 20(1):. PubMed ID: 35049869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of a novel histone deacetylase inhibitor, cyclo{(2S)-2-amino-8-[(aminocarbonyl)hydrazono] decanoyl-1-L-tryptophyl-L-isoleucyl-(2R)-2-piperidinecarbonyl} (SD-2007), and its metabolic conversion to apicidin after intravenous injection and oral administration in rats.
    Shin BS; Bulitta JB; Hong DK; Kim HY; Kim MK; Choi Y; Lee JB; Hwang SW; Lee MH; Yoo SD
    Chemotherapy; 2011; 57(3):259-67. PubMed ID: 21597290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.